Daniel Gilden

880 total citations
23 papers, 699 citations indexed

About

Daniel Gilden is a scholar working on Economics and Econometrics, General Health Professions and Geriatrics and Gerontology. According to data from OpenAlex, Daniel Gilden has authored 23 papers receiving a total of 699 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Economics and Econometrics, 5 papers in General Health Professions and 4 papers in Geriatrics and Gerontology. Recurrent topics in Daniel Gilden's work include Healthcare Policy and Management (6 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Glaucoma and retinal disorders (3 papers). Daniel Gilden is often cited by papers focused on Healthcare Policy and Management (6 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Glaucoma and retinal disorders (3 papers). Daniel Gilden collaborates with scholars based in United States and United Kingdom. Daniel Gilden's co-authors include Joanna Kubisiak, Mark Monane, Daniel E. Everitt, Jerry H. Gurwitz, Jerry Avorn, Robert J. Glynn, S. Rao, Namirah Jamshed, George Taler and Arthur S. Zbrozek and has published in prestigious journals such as American Journal of Public Health, Journal of the American Geriatrics Society and The Journals of Gerontology Series A.

In The Last Decade

Daniel Gilden

22 papers receiving 664 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Gilden United States 12 194 189 168 166 87 23 699
Appathurai Balamurugan United States 15 80 0.4× 148 0.8× 88 0.5× 91 0.5× 9 0.1× 35 683
Nico Schneider Germany 13 47 0.2× 116 0.6× 57 0.3× 25 0.2× 24 0.3× 47 676
Jason Tan Australia 13 420 2.2× 86 0.5× 142 0.8× 12 0.1× 10 0.1× 23 805
Ulf Seifart Germany 17 72 0.4× 149 0.8× 218 1.3× 36 0.2× 3 0.0× 46 820
Hassan Eftekhar Iran 16 13 0.1× 208 1.1× 146 0.9× 31 0.2× 14 0.2× 36 728
Leslie A. Gillum United States 9 50 0.3× 102 0.5× 206 1.2× 87 0.5× 4 0.0× 11 917
Sabina Sanghera United Kingdom 11 18 0.1× 119 0.6× 90 0.5× 132 0.8× 8 0.1× 23 524
Ola Akinboboye United States 7 10 0.1× 127 0.7× 238 1.4× 118 0.7× 11 0.1× 11 609
C. Le Pen France 12 115 0.6× 87 0.5× 143 0.9× 145 0.9× 8 0.1× 30 689
Megan Moncur United States 8 7 0.0× 141 0.7× 65 0.4× 201 1.2× 21 0.2× 12 793

Countries citing papers authored by Daniel Gilden

Since Specialization
Citations

This map shows the geographic impact of Daniel Gilden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Gilden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Gilden more than expected).

Fields of papers citing papers by Daniel Gilden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Gilden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Gilden. The network helps show where Daniel Gilden may publish in the future.

Co-authorship network of co-authors of Daniel Gilden

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Gilden. A scholar is included among the top collaborators of Daniel Gilden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Gilden. Daniel Gilden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gilden, Daniel, Joanna Kubisiak, Gerhardt Pohl, et al.. (2016). Treatment patterns and cost-effectiveness of first line treatment of advanced non-squamous non-small cell lung cancer in Medicare patients. Journal of Medical Economics. 20(2). 151–161. 13 indexed citations
2.
Gilden, Daniel, Joanna Kubisiak, Khaled Sarsour, & Craig Hunter. (2015). Diagnostic Pathways to Alzheimer Disease. Alzheimer Disease & Associated Disorders. 29(4). 330–337. 11 indexed citations
3.
Adams, Alyce S., Stephen B. Soumerai, Fang Zhang, et al.. (2015). Effects of Eliminating Drug Caps on Racial Differences in Antidepressant Use Among Dual Enrollees With Diabetes and Depression. Clinical Therapeutics. 37(3). 597–609. 12 indexed citations
4.
Gilden, Daniel, Joanna Kubisiak, Kristin Kahle‐Wrobleski, Daniel Ball, & Lee Bowman. (2014). Using U.S. Medicare records to evaluate the indirect health effects on spouses: a case study in Alzheimer’s disease patients. BMC Health Services Research. 14(1). 291–291. 22 indexed citations
5.
Jamshed, Namirah, et al.. (2014). Effects of Home‐Based Primary Care on Medicare Costs in High‐Risk Elders. Journal of the American Geriatrics Society. 62(10). 1825–1831. 131 indexed citations
6.
Zhang, Fang, et al.. (2012). Intended and Unintended Consequences of the Gabapentin Off-Label Marketing Lawsuit Among Patients With Bipolar Disorder. The Journal of Clinical Psychiatry. 73(11). 1388–1394. 8 indexed citations
7.
Gilden, Daniel, Joanna Kubisiak, & Arthur S. Zbrozek. (2011). The economic burden of Medicare-eligible patients by multiple sclerosis type. Value in Health. 14(1). 61–69. 23 indexed citations
8.
Hendricks, Ann, John A. Gardner, Austin B. Frakt, et al.. (2010). What can Medicaid data add to research on VA patients?. The Journal of Rehabilitation Research and Development. 47(8). 773–773. 9 indexed citations
9.
Adams, Alyce S., Fang Zhang, Robert F. LeCates, et al.. (2009). Prior Authorization for Antidepressants in Medicaid. Archives of Internal Medicine. 169(8). 750–750. 33 indexed citations
10.
Bishop, Christine E., Andrew M. Ryan, Daniel Gilden, Joanna Kubisiak, & Cindy Parks Thomas. (2009). Effect of an Expenditure Cap on Low‐Income Seniors' Drug Use and Spending in a State Pharmacy Assistance Program. Health Services Research. 44(3). 1010–1028. 6 indexed citations
11.
Kubisiak, Joanna, et al.. (2007). Managing Medicare’s HIV Caseload in the Era of Suppressive Therapy. American Journal of Public Health. 97(6). 1053–1059. 7 indexed citations
12.
Slayter, Elspeth, Deborah W. Garnick, Joanna Kubisiak, et al.. (2006). Injury Prevalence Among Children and Adolescents With Mental Retardation. Mental Retardation. 44(3). 212–223. 21 indexed citations
13.
Rao, S., Joanna Kubisiak, & Daniel Gilden. (2004). Cost of Illness Associated with Metastatic Breast Cancer. Breast Cancer Research and Treatment. 83(1). 25–32. 70 indexed citations
14.
Gilden, Daniel. (2003). "Pocho" y la identidad del chicano. Espéculo: Revista de Estudios Literarios. 38.
15.
Bishop, Christine E., et al.. (2002). Medicare Spending For Injured Elders: Are There Opportunities For Savings?. Health Affairs. 21(6). 215–223. 22 indexed citations
16.
Stuart, Bruce, Becky A. Briesacher, Frank M. Ahern, et al.. (1999). Drug use and prescribing problems in four state Medicaid programs.. PubMed. 20(3). 63–78. 2 indexed citations
17.
Gilden, Daniel, et al.. (1998). Linked Data Analysis of Dually Eligible Beneficiaries in New England.. PubMed. 20(2). 91–108. 7 indexed citations
18.
Bohn, Rhonda L., Robert J. Glynn, Jerry H. Gurwitz, et al.. (1994). Patterns of Glaucoma Medication Use in the Elderly. Journal of Glaucoma. 3(3). 259???264–259???264. 2 indexed citations
19.
Gurwitz, Jerry H., Robert J. Glynn, Mark Monane, et al.. (1993). Treatment for glaucoma: adherence by the elderly.. American Journal of Public Health. 83(5). 711–716. 233 indexed citations
20.
Avorn, Jerry, Robert J. Glynn, Jerry H. Gurwitz, et al.. (1993). Adverse Pulmonary Effects of Topical ?? Blockers Used in the Treatment of Glaucoma. Journal of Glaucoma. 2(3). 158???165–158???165. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Appathurai Balamurugan Breakdown of academic impact, for papers by Nico Schneider Breakdown of academic impact, for papers by Jason Tan Breakdown of academic impact, for papers by Ulf Seifart Breakdown of academic impact, for papers by Hassan Eftekhar Breakdown of academic impact, for papers by Leslie A. Gillum Breakdown of academic impact, for papers by Sabina Sanghera Breakdown of academic impact, for papers by Ola Akinboboye Breakdown of academic impact, for papers by C. Le Pen Breakdown of academic impact, for papers by Megan Moncur
Rankless by CCL
2026